- #1
Winzer
- 598
- 0
When it comes to a cure, where are we with these diseases? What are the challenges with coming up with a cure?
Winzer said:When it comes to a cure, where are we with these diseases? What are the challenges with coming up with a cure?
Wouldn't a positive attitude also favor cell divisions and so cancer? Just curious.I think that on an individual basis, stopping cancerous growth and/or the depletion of the immune system (HIV) can be initiated through the attitudes and morale of the patient. This is a tough call since the person we're asking to have a bright and sunny attitude is the one facing the illness and its symptoms. But, with this sort of attitude the patient is much better equipped to fight the disease, simply because their immune system is pumped up by the secretion of the hormones that are produced by a specifically good outlook.
Is there any evidence that this is true? You would need a tightly controlled study to be able to prove such a point.baywax said:But, with this sort of attitude the patient is much better equipped to fight the disease, simply because their immune system is pumped up by the secretion of the hormones that are produced by a specifically good outlook.
Let's first find out whether the first claim is true, before postulating such a question.fluidistic said:Wouldn't a positive attitude also favor cell divisions and so cancer? Just curious.
Monique said:Is there any evidence that this is true? You would need a tightly controlled study to be able to prove such a point.
fluidistic said:Wouldn't a positive attitude also favor cell divisions and so cancer? Just curious.
Proton Soup said:just an anecdote, but a friend who works as an oncology nurse tells me that almost everyone with cancer does not get cured. it almost always returns. so it's mostly a managed disease, like AIDS.
baywax said:No one knows that for sure. Like I said you and I have probably developed cancer during our lives then had our immune system deal with the condition without our knowledge.
In fact, they are finding that women who undergo mammography are diagnosed too hastily because many of the tiny legions and tumours in their breasts could well be taken care of by their own immune system. Then they go on to these trying treatments that stress the living **** out of them and things get worse from there on.
Proton Soup said:this isn't really saying anything except that people under high stress have lower life expectancy than people under low stress. i don't think there's anything new here. or that it makes a difference if one has cancer or not.
Ygggdrasil said:Certainly the immune system can be very helpful in dealing with cells that divide uncontrollably, but one of the hallmarks of cancer is resistance to the immune response. For example, most cancer cells develop a resistance to apoptosis (as mentioned by baywax) which renders them resistant to certain immune responses (e.g. from cytotoxic t-cells). Furthermore, cancer cells often downregulate the expression of MHC proteins and other immunological markers to evade detection by the body's immune system.
There are certainly going to be some cases of cancer where boosting the body's immune system (through any number of means, phamacologically or otherwise) can be very helpful in battling a cancer. There will also be many cases, however, where the cancer cannot be battled effectively by the body's own immune system and immunotherapy will not be helpful at all.
Although I am not a doctor, I would also contest the assertions that surgery leads to metastasis and that radiation therapy makes cancer more aggressive.
Anyway, one major challenge with treating cancer is that cancer is not one disease. Cancer can affect a number of different tissue types which all pose unique challenges in the progression and treatment of the disease. Furthermore, even among classes of similar cancers, every cancer in every individual is unique. Thus, fighting cancer requires a number of different strategies which may work for some cancers but not for others. Thus, we shouldn't necessarily say that one treatment is superior to another. In some cases, immunotherapy will work best. In other cases, surgery, drugs, radiation, or some combination of therapies may be the best prescription. What onocology really needs is a revolution in DNA sequencing technologies to realize the dream of personalized medicine. With rapid, cheap DNA sequencing available, doctors could quickly identify the exact mutations that make a cancer cell cancerous and choose specific drugs or therapies tailored to that specific cancer.
Certain types of brain cancer cells, called cancer stem cells, help brain tumors to buffer themselves against radiation treatment by activating a "repair switch" that enables them to continue to grow unchecked, researchers at Duke University Medical Center have found.
Autophagy or "self eating" is frequently activated in tumor cells treated with chemotherapy or irradiation. Whether autophagy represents a survival mechanism or rather contributes to cell death remains controversial. To address this issue, the role of autophagy in radiosensitive and radioresistant human cancer cell lines in response to gamma-irradiation was examined. We found irradiation-induced accumulation of autophagosomes accompanied by strong mRNA induction of the autophagy-related genes beclin 1, atg3, atg4b, atg4c, atg5, and atg12 in each cell line. Transduction of specific target-siRNAs led to down-regulation of these genes for up to 8 days as shown by reverse transcription-PCR and Western blot analysis. Blockade of each autophagy-related gene was associated with strongly diminished accumulation of autophagosomes after irradiation. As shown by clonogenic survival, the majority of inhibited autophagy-related genes, each alone or combined, resulted in sensitization of resistant carcinoma cells to radiation, whereas untreated resistant cells but not sensitive cells survived better when autophagy was inhibited. Similarly, radiosensitization or the opposite was observed in different sensitive carcinoma cells and upon inhibition of different autophagy genes. Mutant p53 had no effect on accumulation of autophagosomes but slightly increased clonogenic survival, as expected, because mutated p53 protects cells by conferring resistance to apoptosis. In our system, short-time inhibition of autophagy along with radiotherapy lead to enhanced cytotoxicity of radiotherapy in resistant cancer cells.
Breast cancer stem cells, seem to be obstinate, as scientists have discovered, as they portray a resistance to radiation therapy. As a result, they are extremely// difficult to annihilate. In fact radiation could even increase the growth of these stem cells, warn researchers from the University of California, Los Angeles, who are the first to have suggested this tendency of stem cells that get radiation resistant and render breast cancer treatments futile.
Proton Soup said:why would a virus need nutrition, or die from lack of it?
L-lysine, an essential amino acid, has been studied for its ability to reduce the reactivation rate of herpes (Flodin NW 1997; Marcason W 2003). It works by inhibiting the action of L-arginine during viral replication. Proteins within herpes are rich in L-arginine. An altered ratio of L-lysine to L-arginine, in favor of L-lysine, has been studied for its ability to inhibit the virus. While the results of some studies have been mixed, the following studies have shown L-lysine’s ability to inhibit herpes:
In a double-blind, multi-centered, placebo-controlled study evaluating L-lysine for the prevention and treatment of recurrent herpes infection, one group received 1000 mg of L-lysine three times daily for 6 months. This group had significantly fewer outbreaks, less severe symptoms, and more rapid healing. The researchers said that L-lysine was an effective agent for reducing the occurrence, severity, and symptoms of herpes (Griffith RS et al 1987).
In a second prospective, randomized, double-blind, placebo-controlled, cross-over study, oral intake of L-lysine (1248 mg daily) decreased the recurrence of herpes simplex in people with healthy immunity. A dose of 624 mg per day was not effective. L-lysine may also decrease the severity of symptoms associated with recurrences. Neither dosage shortened healing time (McCune MA et al 1984).
In a double-blind clinical study examining the long-term prophylactic efficacy of L-lysine supplementation for herpes labialis, volunteers who had a history of frequent outbreaks were recruited. The treatment group received daily oral supplements of 1000 mg of L-lysine. The L-lysine treatment group had significantly fewer outbreaks than the control group. Volunteers who were taken off L-lysine generally showed a significant increase in the recurrence of lesions. Data revealed fewer lesions when a person's serum L-lysine concentration exceeded 165 nanomoles per milliliter (nmol/mL) and increased significantly as concentration levels fell below 165 nmol/mL. These results suggest that prophylactic L-lysine may be useful in managing selected cases of recurrent herpes labialis (Thein DJ et al 1984).
Foods rich in L-lysine include legumes, eggs, yogurt, fish, and chicken (Balch PA et al 2000; Jamison JR 2004). Taking L-lysine with vitamin C and bioflavonoids together has been shown to reduce the risk of herpetic outbreaks (Balch PA et al 2000).
jreelawg said:The medicinal uses of trametes versicolor may be very promising in helping fight both cancer, HIV, and lots of other things as well. Compounds derived from it exhibit anti viral, anti tumor, and immune system boosting properties.
You probably don't believe me now, but if you do your research, I think you will be surprised at the awesomeness of this organism. You will wonder why you and your doctor have never heard of it.
jreelawg said:You probably don't believe me now, but if you do your research, I think you will be surprised at the awesomeness of this organism. You will wonder why you and your doctor have never heard of it.
baywax said:I don't believe or disbelieve you now. It would be helpful if you'd post a link to a study that proves the claim.
Proton Soup said:Salk also had some weird ideas about vitamin C.
lisab said:Maybe you're thinking of Pauling?
The current state of disease research and finding cures is constantly evolving and improving. Scientists and researchers are continuously conducting studies and experiments to better understand diseases and develop effective treatments and cures. With advancements in technology and collaboration among experts, there is hope for finding cures for many diseases in the near future.
There are multiple factors that influence the prioritization of diseases for research, such as prevalence, mortality rate, and impact on public health. Scientists also consider the potential for breakthroughs and the availability of resources and funding when selecting which diseases to focus on.
There are numerous challenges that scientists face in finding cures for diseases. Some of these challenges include limited funding, lack of access to data and resources, ethical considerations, and the complexity of certain diseases. Additionally, the process of developing and testing potential cures can be lengthy and unpredictable.
Collaboration among scientists is crucial in the search for cures. This can involve sharing data and resources, conducting joint studies and experiments, and communicating findings and strategies. Collaborative efforts can lead to more efficient and effective research, ultimately increasing the chances of finding cures for diseases.
There are many ways that the general public can support the search for cures. This can include donating to research organizations, participating in clinical trials, advocating for increased funding for disease research, and staying informed about current advancements and breakthroughs. Additionally, individuals can make lifestyle choices that promote overall health and reduce the risk of developing certain diseases.